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This study was conducted to check whether the three chick Early B-cel Factor (Ebf) genes, particularly cEbf1, 
would be targets for Shh and Bmp signals during somites mediolateral (ML) patterning. Tissue manipulations 
and gain and loss of function experiments for Shh and Bmp4 were performed and the results revealed that 
cEbf1 expression was initiated in the cranial presomitic mesoderm by low dose of Bmp4 from the lateral 
mesoderm and maintained in the ventromedial part of the epithelial somite and the medial sclerotome by 
Shh from the notochord; while cEbf2/3 expression was induced and maintained by Bmp4 and inhibited by 
high dose of Shh. To determine whether Ebf1 plays a role in somite patterning, transfection of a dominant- 
negative construct was carried out; this showed suppression of cPax1 expression in the medial sclerotome 
and upregulation and medial expansion of cEbf3 and cPax3 expression in sclerotome and dermomyotome, 
respectively, suggesting that Ebf1 is important for ML patterning. Thus, it is possible that low doses of Bmp4 
set up Ebf1 expression which, together with Shh from the notochord, leads to establishment of the medial 
sclerotome and suppression of lateral identities. These data also conclude that Bmp4 is required in both 
the medial and lateral domain of the somitic mesoderm to keep the ML identity of the sclerotome through 
maintenance of cEbf gene expression. These striking findings are novel and give a new insight on the role of 








The chick Ebf (early B-cel factor) genes are members of a novel highly conserved family of atypical 
helix–loop–helix (HLH) transcription factors, EBF. The chick embryo has three EBF proteins encoded by 
distinct genes, designated cEbf1 through 3 (El-Magd, Alen, McGonnel, Otto, & Patel, 2013; Mela, Soula, 
Morelo, Crozatier, & Vincent, 2004). EBF proteins are composed of five domains; DNA binding domain 
(DBD), immunoglobulin-like plexins transcription factor (IPT), atypical HLH, transactivation I domain (TSI), 
and transactivation II (TSII) domain and are originaly discovered in rodents as a protein that regulates the 
diferentiation of B-lymphocyte (Crozatier, Vale, Dubois, Ibnsouda, & Vincent, 1996). Our previous studies 
in addition to others demonstrated the importance of EBF for tissue specification, diferentiation, and cel 
movements during development of nervous, adipose, muscular, and skeletal tissues as wel as feathers and 
bone marrow (El-Magd, Saleh, El-Aziz, & Salama, 2014; El-Magd, Sayed-Ahmed, Awad, & Shukry, 2014; 
Moruzzo et al., 2017; Seike, Omatsu, Watanabe, Kondoh, & Nagasawa, 2018; Tolkin & Christiaen, 2016; Zee et 
al., 2013). 
 
The mesoderm is subdivided along the mediolateral (ML) direction into somites and the lateral 
(intermediate and lateral plate) mesoderm, with a sharp morphological boundary between them (Danesh, 
Vilasenor, Chong, Soukup, & Cleaver, 2009; Schoenwolf, Garcia-Martinez, & Dias, 1992). The medial and 
lateral parts of somites are derived from cels in diferent parts of the primitive streak/node (Psychoyos & 
Stern, 1996; Seleck & Stern, 1991). This ML subdivision corresponds functionaly to the segregation between 
epaxial and hypaxial musculature and is independent of dermomyotome/sclerotome subdivision (Ordahl & 
Le Douarin, 1992; Pourquie et al., 1996; Pourquie, Coltey, Breant, & Le Douarin, 1995). Some genes are 
diferentialy expressed along the ML axis of the somites, such as SWiP1 (expressed in the medial part 
of somite), Pax1, and Ebf1 (expressed mainly in the medial sclerotome), Ebf3 (expressed in the lateral 
sclerotome), Pax3 (expressed throughout the dermomyotome, with elevated levels only in the lateral 
dermomyotomal lips), and Sim1 (labeled first the entire lateral half of the epithelial somite, and then the 
lateral dermomyotome and sclerotome; (El-Magd et al., 2013; El-Magd et al., 2015; Olivera-Martinez, Missier, 
Fraboulet, Thélu, & Dhouaily, 2002; Pourquie et al., 1996; Stern & Piatkowska, 2015; Tonegawa et al., 1997; 
Vasiliauskas, Hancock, & Stern, 1999). 
 
Diferent levels of Bmp4 activity control the ML subdivision of the mesoderm: a high level produces the 
lateral plate, whereas a moderate level forms the intermediate mesoderm and a low level determines the 
lateral portion of the somite (Pourquie et al., 1996; Tonegawa et al., 1997). Although the notochord expresses 
both Chordin and Noggin as inhibitors of BMP, only Noggin can antagonize the lateralization efect of the 
lateral mesoderm-derived Bmp4 on the paraxial mesoderm (McMahon et al., 1998; Staford, Brunet, Khokha, 
Economides, & Harland, 2011; Staford, Monica, & Harland, 2014; Streit & Stern, 1999). Any disturbance in 
the balance between the lateralizing and medializing efects of Bmp4 and Noggin, respectively, results in a loss 
of ML polarity of the paraxial and lateral plate mesoderm (reviewed by Stern & Piatkowska, 2015). In line with 
this idea, when the presumptive part of the crPSM forming somite is transplanted into the lateral plate-fated 
region of chick embryo, the somite is respecified to lateral plate mesoderm (Garcia-Martinez & Schoenwolf, 
1992) due to the lateralizing efect of Bmp4 (Pourquie et al., 1996; Tonegawa et al., 1997). Conversely, the 
lateral plate-fated tissue is redirected to the somite when transplanted into the paraxial mesoderm region 
(Garcia-Martinez & Schoenwolf, 1992), and this efect is attributed to the notochord-derived Noggin (Pourquie 
et al., 1996; Tonegawa et al., 1997). In addition, implantation of Bmp4 expressing cels between the neural 
tube (NT) and PSM induces expression of the lateral dermomyotomal/sclerotomal marker Sim1 in the medial 
regions of the dermomyotome/sclerotome of the diferentiated somites, resulting in lateralization of the 
somites (Pourquie et al., 1996). Moreover, somites of embryos with higher Bmp signaling are smaler and 
lost caudaly because paraxial mesoderm cels are aberrantly specified as lateral mesoderm (Staford et al., 
2014). Likewise, loss of BMP4 relieves the lateralization of the paraxial mesoderm observed in Noggin mutant 
embryos (Wijgerde, Karp, McMahon, & McMahon, 2005). Similarly, ectopic application of Noggin expressing 
cels in the presumptive lateral plate mesoderm results in ectopic somites (Tonegawa & Takahashi, 1998). In 
addition to Noggin, Shh is also required to maintain the medial identity of the somites through regulation of 
the medial sclerotomal marker, Pax1 (Borycki, Mendham, & Emerson, 1998; Cairns, Sato, Lee, Lassar, & Zeng, 
2008). 
 
The medial somitic marker SWiP-1 and the lateral somitic marker Sim1 are regulated by Shh (from the 
notochord) and Bmp4 (from lateral plate/dorsal ectoderm), respectively (Pourquie et al., 1996; Vasiliauskas 
et al., 1999). These previous two studies showed clearly that despite the diferent celular origins of medial 
and lateral somite cels, it is possible to alter the medial or lateral properties within a somite by signals from 
adjacent tissues. Our previous studies also showed that cEbf1 expression in the medial sclerotome is regulated 
by Shh signals from the notochord/floor plate and cEbf2,3 expression in the lateral sclerotome is regulated by 
lateral mesoderm-derived Bmp4 signals (El-Magd et al., 2013, 2015). Although, these earlier data on cEbf gene 
regulation in the somite are consistent with the known roles of Shh and Bmp in the mediolateral patterning 
of somites, they do not address the efect of either the axial structures (notochord/floor plate) and diferent 
concentrations of Shh on cEbf2/3 or the lateral plate mesoderm and Bmp4 on cEbf1 expression in somites. 
Moreover, regulation of early cEbf1 expression in the crPSM was not addressed in our previous studies. 
Therefore, we conducted this study to fil in these gaps and to check whether cEbfs, particularly cEbf1, could be 
downstream targets in Shh and Bmp4 signaling cascade regulating the mediolateral patterning of the somites. 
To reach this goal, we constructed a negative dominant form of Ebf1 to monitor mediolateral patterning of 






2.1 Tissues control cEbfs gene expression along the mediolateral axis of somitic 
mesoderm 
 
In our previous studies, we have performed the folowing three tissue manipulation experiments to 
determine tissues regulating cEbf genes in somites: notochord ablation for cEbf1, lateral barrier insertion, and 
NT ablation for cEbf2/3 (El-Magd et al., 2013, 2015). However, these three manipulations are not enough to 
get a final conclusion about the mediolateral regulation of these genes. Therefore, in the present study, we 
performed some additional tissue manipulation experiments, including medial barrier insertion, removal of 
axial structures, notochord ablation (for cEbf2/3), and NT ablation and lateral barrier insertion (for cEbf1), to 
detect the efect of the axial structures on the lateral sclerotomal markers, cEbf2/3, and the efect of the lateral 
mesoderm and NT on the medial sclerotomal marker, cEbf1. 
 
Table 1 shows al details regarding the tissue manipulations including the manipulation stages (at operation 
time and at the end of reincubation), manipulation site (either crPSM or epithelial somites), and number of 
embryos showing the phenotype and altered cEbf genes expression. 
Table 1 Details of the tissue manipulation experiments  
 
Number of embryos showing a phenotype or an altered gene expression 
 
Name of manipulation Anatomical region Stage manipulation was performed Stage embryos were harvested Number of embryos alive at harvesting cEbf1 cEbf2 cEbf3 
 
Medial barrier insertion crPSM HH11-HH12 HH15-HH17 21 7 6 6 
Axial structures ablation crPSM HH12 HH17 21 7 6 6 
Medial barrier insertion ES HH12 HH17 21 7 6 6 
Medial barrier insertion caPSM HH14 HH17 5 5 – – 
Notochord removal crPSM HH12 HH16-HH17 20 – 8 8 
Neural tube ablation crPSM HH12 HH16 12 12 – – 
 ES HH12 HH17 10 10 – – 
Lateral barrier insertion crPSM HH12 HH17 7 6 – – 
 ES HH12 HH17 7 6 – – 
New culture (control) WE HH12 HH17 14 – 7 7 
Cyclopamine treatment WE HH12 HH17 14 – 6 6 
Control PBS beads crPSM HH12-HH13 HH17-HH18 8 – 2 6 
SHH beads (0.5 μg/μl) crPSM HH12-HH13 HH17-HH18 20 – 10 10 
SHH beads (1 μg/μl) crPSM HH12-HH13 HH17-HH18 20 – 8 9 
SHH beads (2 μg/μl) crPSM HH12-HH13 HH17-HH18 20 – 8 8 
DF-1 cels (control) Lateral to crPSM HH12 HH18 7 6 – – 
Noggin secreting cels Lateral to crPSM HH12 HH18 7 6 – – 
Noggin secreting cels Lateral to ES HH12 HH18 7 6 – – 
DF-1 cels (control) Lateral to ES HH12 HH17-HH18 7 6 – – 
Noggin secreting cels Medial to crPSM HH12 HH17-HH18 7 6 – – 
Noggin secreting cels Medial to ES HH12 HH17-HH18 7 7 – – 
Bmp4 beads (50 μg/ml) crPSM HH11-HH13 HH17-HH18 8 7 – – 
Bmp4 beads (100 μg/ml) crPSM HH12 HH17 7 7 – – 
Bmp4 beads (150 μg/ml) crPSM HH12 HH17 7 7 – – 
 
Abbreviations: caPSM, caudal part of presomitic mesoderm; crPSM, cranial part of presomitic mesoderm; ES, epithelial somites; WE, whole embryo. 
2.1.1 Efect of medial barrier insertion and removal of axial structures on cEbf gene 
expression 
 
To investigate the influence of signals from axial structures on cEbf gene expression, both the notochord 
and the NT were separated from the crPSM by an aluminum foil barrier spanning 5–8 prospective somites 
of chick embryos (Figure 1a–c). This manipulation resulted in very smal somites (Marcele, Ahlgren, & 
Bronner-Fraser, 1999; Teilet et al., 1998), which showed complete down-regulation of cEbf1 expression in the 
sclerotome at the operation side as compared to the control nonoperated side (green vs. yelow arrowheads, 
Figure 1d,g), slight down-regulation of cEbf2 sclerotomal expression in the cranial operation region 
(arrowheads, Figure 1e,h), and up-regulation of cEbf3 expression in the lateral sclerotomal portion with slight 




























Figure 1 Efect of medial barrier insertion and axial structures removal on cEbf gene expression. (a) 
Schematic diagram of HH12 chick embryo before commencement of the microsurgery showing the 
operation sites (boxed region). Al whole mount panels are oriented in a similar way to this embryo. (b, c) 
Schematic diagrams (b, dorsal view) and (c, transverse section) showing the position of a medial barrier 
(red line) inserted between the axial structures (the NT and notochord) and the crPSM. (d–I) Whole 
mount in situ hybridization and transverse sections folowing barrier insertion between the axial 
structures and crPSM. (j, k) Schematic diagrams showing the operation site of axial structures ablation at 
level of crPSM. (l–p) HH17 chick embryos after ablation of axial structures at crPSM level. (q, r) Schematic 
diagrams showing the position of a medial barrier (red line) inserted between the axial structures and the 
newly formed five somites (from SI to SV). (s–x) HH17 chick embryos after medial barrier insertion 
between axial structures and epithelial somites. (y) Schematic diagrams showing the position of a medial 
barrier (red line) between the axial structures and the caudal portion of the PSM (Y1) and the position of 
this barrier after 8–10 hr incubation (Y2). (z) HH17 chick embryos after medial barrier insertion at level 
shown in Y2. In al photos, dashed lines indicate the site of transverse sections. Abbreviations: crPSM, 
cranial presomitic mesoderm; DSE, dorsal somitic epithelia; FP, floor plate; IM, intermediate mesoderm; 
LPM, lateral plate mesoderm; N, notochord; NT, neural tube; PSM, presomitic mesoderm; (SI-SV), 
somites 1–5; Scl, sclerotome; Som, somitocoele; VSE, ventral somitic epithelia. Scale bars: d–f, l–n, s–u, 
z = 400 μm, g–i, o, p, v–x = 150 μm 
 
 
To confirm these medial barrier results, the axial structures were ablated at the crPSM level (Figure 1j,k). 
These manipulations gave the same results as using medial barrier at the same level; lack of cEbf1 expression 
in the il-developed somites on both sides of the ablated region (arrowheads, Figure 1l,o), slight reduction of 
cEbf2 expression (arrowheads, Figure 1m) and an increase of cEbf3 expression (arrowheads, Figure 1n,p). 
 
To check the efect of axial tissues on the maintenance of cEbf genes expression, the medial barriers were 
inserted between the epithelial somites (from SI to SV) and the axial structures (Figure 1q,r). The obtained 
results revealed the presence of smal somites and complete loss of cEbf1 expression (arrowheads, Figure 1s,v), 
slight down-regulation of cEbf2 expression (arrowheads, Figure 1t,w) and disorganized, but retained 
expression of cEbf3 (arrowheads, Figure 1u,x) in the sclerotome lateral to the barrier. 
Tissues regulation of the early cEbf1 expression in the crPSM was not investigated in our previous studies 
(El-Magd et al., 2013, 2015). Given that isolation of the PSM from the axial structures causes a striking 
reduction in somite size due to increased apoptosis (Dietrich, Schubert, & Lumsden, 1997), it is possible 
that the absence of cEbf1 folowing ablation of the notochord (El-Magd et al., 2015) may be secondary to 
failure of cEbf1-expressing cels to develop and hence the notochord and probably Shh may not be the initial 
inducer of cEbf1 expression. To check whether the axial structures can induce cEbf1 expression in the crPSM, 
medial barriers were inserted at the level of the caudal PSM in a region spanning six prospective somites 
(Figure 1Y1,Y2). The embryos were operated at HH14 and reincubated for short time (~8–10 hr, HH17). 
During HH14 stage, only cEbf1 expression has already initiated in the cranial portion of the crPSM in a region 
of three prospective somites length (from S0 to S-II) as previously described (El-Magd et al., 2015). During this 
8–10 hr incubation period, the crPSM lateral to the barrier was deprived of contact with the axial structures. 
The PSM lateral to the barrier was formed properly and expressed cEbf1 at a slightly reduced level compared 
to the nonoperated side (green arrowhead, Figure 1z). As expected, no cEbf1 expression in somites formed next 
to the cranial region of the barrier (magenta arrowhead, Figure 1z). This indicates that the axial structures are 
mainly required for maintenance, rather than induction, of cEbf1 expression. 
 
In general, these experiments reveal that the NT and/or notochord are (is) important for maintenance of 
cEbf1 expression and to a lesser extent for induction and maintenance of cEbf2 expression in the somite. In 
contrast, these axial structures appear to repress cEbf3 expression. 
 
 
2.1.2 Efect of notochord removal on cEbf2 and cEbf3 gene expression 
 
Our previous notochord ablation experiment revealed that cEbf1 expression in the medial sclerotome is 
regulated by notochord signals (El-Magd et al., 2015). In contrast, cEbf2 and cEbf3 are expressed lateraly in 
the sclerotome (El-Magd et al., 2013) and so they may be inhibited by medial signals from the notochord. To 
check this, the notochord-floor plate complex was removed at the crPSM level, a length of 4–6 prospective 
somites (Figure 2a). This operation prevents the development of ventral identities in the somite (Dietrich et 
al., 1997) resulting in delayed maturation of somites up to SVII (normaly maturation occurs at SIV-V). These 
somites become smaler and have sharp boundaries. This operation led to loss of cEbf2 expression in the 
ventromedial epithelial somites and became localized only in the somitocoele (green arrowheads, Figure 2c,e). 
However, this manipulation increased cEbf3 expression in the medial somitic domain (green arrowheads, 
Figure 2d,f) as compared to the control (non-operated) embryo (green arrowhead, Figure 2b). These findings 
suggest that the notochord may partialy regulate the medial expression of cEbf2 in the immature somites. 
































Figure 2 The efect of notochord removal, and neural tube (NT) removal a on cEbfs expression. (a) 
Schematic diagrams showing the operation site of axial notochord ablation at level of crPSM. (b) Whole 
mount in situ hybridization shows cEbf3 expression in control (nonoperated) embryo. (c–f) Whole mount 
in situ hybridization and transverse sections at the levels of SVI folowing notochord and floor plate 
removal at crPSM level. (g, h) Schematic diagrams showing the operation site of NT ablation at level of 
crPSM. (i, j) Chick embryos folowing NT removal at crPSM show cEbf1 expression. (k, l) Schematic 
diagrams showing the operation site of NT ablation at level of epithelial somites. (m, n) Chick embryos 
folowing NT removal at epithelial somites. The regions between the two magenta and the two green 
arrowheads are the operation sites. In al photos, dashed lines indicate the site of transverse sections. 
Abbreviations: crPSM, cranial presomitic mesoderm; DSE, dorsal somitic epithelia; FP, floor plate; IM, 
intermediate mesoderm; LPM, lateral plate mesoderm; N, notochord; NT, neural tube; PSM, presomitic 
mesoderm; SI-SV, somites 1–5; Scl, sclerotome; Som, somitocoele; VSE, ventral somitic epithelia. Scale 




2.1.3 Neural tube ablation does not afect cEbf expression 
 
Our previous study showed that NT ablation does not change cEbf2,3 expression in the somites (El-Magd et 
al., 2013). Although, we know from our previous study that cEbf1 regulation is mediated by signals from the 
notochord (El-Magd et al., 2015), it is also important to check whether the NT plays a role in that regulation. 
To determine this efect, the NT alone was removed at the level of the crPSM of HH11 embryos (Figure 2g,h). 
This operation often leads to the pairwise fusion of right and left crPSM forming a singular row of somites 
comprising of a dorsal epithelia cap (thought to be dermomyotome) and a ventral mesenchymal tissue (the 
sclerotome) (arrowhead, Figure 2i,j). Despite the absence of the NT and the new midline location of the 
somites, cEbf1 gene expression remained relatively unchanged in the entire sclerotome ventral to the fused 
dorsal dermomyotome and adjacent to the notochord. The NT is therefore not necessary for induction of cEbf1 
expression in epithelial somites. 
To check whether the NT can maintain cEbf1 gene expression in somites, the NT was ablated at the level 
of the newly formed five somites of HH12 embryos (Figure 2k,l). After ~16 hr of reincubation, normal cEbf1 
expression was remained in the sclerotomal cels around the notochord (Figure 2m,n). Thus, the NT has no 
role in maintenance of cEbf1 expression in somites. 
 
 
2.1.4 Efect of lateral structures on cEbf1 gene expression in the somites 
 
We have previously found that cEbf2 and cEbf3 expression in the lateral sclerotome is regulated by Bmp4 
signals from the lateral mesoderm (intermediate [IM] and lateral plate mesoderm [LPM]; El-Magd et al., 
2013). In addition, results of the current study reported that the initiation of cEbf1 expression in the crPSM 
in isolation from axial structures also argues for induction of cEbf1 by other surrounding structures. Taken 
together, it is therefore possible that the lateral structures can initiate the cEbf1 expression in somites. 
To test this possibility, the crPSM of HH12 embryo was separated from the IM/LPM by insertion of an 
impermeable barrier with length of 5–9 prospective somites (Figure 3a,b). Surprisingly, cEbf1 expression was 
completely lost in the sclerotome medial to the barrier unlike the control somites on the contralateral sides 
(green arrowhead, Figure 3c,d). Insertion of barriers between the newly formed 5–8 somites and the IM/LPM 
(Figure 3e,f) resulted in a slight reduction in the most lateral edge of the cEbf1 expression domain in the 
sclerotome (arrowhead, Figure 2g,h). These findings indicate that the lateral tissues or factors emanating from 

































Figure 3 The efect of lateral barrier insertion on cEbfscEbf1 expression. (a, b) Schematic diagrams 
showing the operation site of lateral barrier insertion (red line) at level of crPSM. (c, d) HH17 chick 
embryos folowing lateral barriers insertion between IM/LPM and crPSM show cEbf1 expression. (e, f) 
Schematic diagrams showing the operation site of lateral barrier insertion (red line) at level of epithelial 
somites. (g, h) HH17 chick embryos folowing lateral barriers insertion between IM/LPM and epithelial 
somites. In al photos, dashed lines indicate the site of transverse sections. Abbreviations: crPSM, cranial 
 
presomitic mesoderm; FP, floor plate; IM, intermediate mesoderm; LPM, lateral plate mesoderm; N, 




2.2 Molecular regulation of Ebfs gene expression 
 
Our previous studies showed that Shh mediates the signal from the notochord that maintains cEbf1 gene 
expression in somites (El-Magd et al., 2015) and that the lateral plate-derived Bmp4 induces and maintains 
cEbf2 and cEbf3 expression in somites (El-Magd et al., 2013). In these two previous studies, the efect of Shh 
on cEbf2/3 and the efect of Bmp4 on cEbf1 were not addressed. Again to get an overal view regarding the 
mediolateral regulation of cEbf genes in the somites, herein we used Shh and Bmp4 gain and loss of function 
experiments to determine this efect. 
 
 
2.2.1 Efect of inhibition of Shh by cyclopamine on cEbf2 and cEbf3 expression 
 
To identify whether cEbf2 and cEbf3 expression could be altered upon specific inhibition of Shh, 
embryos were placed in a New culture system and treated with cyclopamine as was previously described 
(El-Magd et al., 2015). Loss of cPax1 expression in cyclopamine-treated embryos as compared to control 
(untreated) embryos, confirmed that Shh has been successfuly inhibited by this treatment (Figure 4a,b). 
Morphological characteristics were also used to ascertain that Shh was successfuly inhibited. Some head 
malformations, including holoprosencephaly (blue arrowhead, Figure 4e), il-developed mesencephalon 
(yelow arrowhead, Figure 4e), and atrophied pharyngeal arches especialy the first arch (black arrowhead, 
Figure 4e), were occurred 1 day after cyclopamine treatment similar to cyclopamine-induced malformations 
reported by our previous study and by other studies (Cordero et al., 2004; El-Magd et al., 2015; Incardona, 
Gafield, Kapur, & Roelink, 1998). Although, there was no cyclopia, as embryos were treated after formation 
of optic vesicle, the two eyes developed closer to each other (magenta arrowhead, Figure 4e). In contrast, the 
same stage control embryos did not show such malformations (Figure 4f). Unlike complete loss of cEbf1 in 
cyclopamine-treated embryos (El-Magd et al., 2015), the expression of cEbf2 (Figure 4c) and cEbf3 (Figure 4e) 
in cyclopamine-treated embryos was similar to that in the control embryos (Figure 4d,f). Therefore, Shh is not 
































Figure 4 Efect of Shh gain and loss function on cEbf2 and cEbf3 expression. (a–f) Whole mount in situ 
hybridization of HH16-HH17 embryos folowing either cyclopamine (a, c, e) or PBS (control; b, d, f) 
treatment shows expression of cPax, cEbf2, and cEbf3. (g, h) Schematic diagrams, (g, dorsal view) and (h, 
transverse section) show the position of the implanted Afigel bead (arrowheads). (i–v) HH17-18 embryos 
folowing implantation of either PBS beads (i, j), or SHH beads at concentrations of 0.5 μg/μl (k–n), 1 μg/ 
μl (o–r), and 2 μg/μl (s–v) in the crPSM. The magenta arrowheads refer to the beads. Abbreviations: Ca, 
caudal; Cr, cranial; crPSM, cranial presomitic mesoderm; IM, intermediate mesoderm; LPM, lateral plate 
mesoderm; N, notochord; NT, neural tube; PBS, phosphate bufered saline; PSM, presomitic mesoderm; 




2.2.2 Ectopic expression of Shh down-regulates cEbf2 and cEbf3 somitic expression 
 
To check the efect of Shh ectopic expression on cEbf2 and cEbf3 expression in somites, phosphate bufered 
saline (PBS; as control) or Shh-loaded Afigel beads were implanted into the crPSM (magenta arrowheads, 
Figure 4). The control embryos, implanted with PBS beads (magenta arrowheads) showed normal cEbf3 
expression in the sclerotome and there is a normal developed dermomyotome (Figure 4gi,hj). However, 
implantation of 0.5 μg/μl Shh-loaded beads (magenta arrowheads) resulted in either unafected, or very 
slightly reduced somitic expression of cEbf2 and cEbf3 (Figure 4). 
 
Because Shh acts as a morphogen, that is, it has a dose-dependent function, we tested whether higher 
concentration of Shh can alter the expression of cEbf2 and cEbf3 genes. Loading beads (magenta arrowheads) 
with 1 μg/μl Shh slightly decreased the intensity, but not the domain, of cEbf2  and  cEbf3  expression 
(Figure 4m,Po-r). Moreover, much higher concentration 2 μg/μl completely down regulates the expression of 
cEbf2 and cEbf3 in the somites (Figure 4). 
 
These results indicated that only a very high dose of exogenous Shh can antagonize the lateral signals which 
are necessary to keep the lateral identity of cEbf2 and cEbf3 expressing cels. However, in the absence of any 
information on the concentration of Shh protein that difuses out of the bead, estimation of the efective dose 
of Shh remains speculative. 
 
 
2.2.3 Inhibition of Bmp2/4 blocks cEbf1 gene expression 
 
Experimentaly, Bmp2/4 function can be abrogated by local implantation of chick DF-1 fibroblast cels 
transfected with a mammalian Noggin-RCASBP(A) virus (El-Magd et al., 2013). In this prior study, we found 
that implantation of Noggin secreting cels medial to the crPSM resulted in a complete loss of cEbf2 and a 
partial loss for cEbf3 expression (El-Magd et al., 2013). However, when these cels were implanted medial to 
the epithelial somites, they resulted in a slight loss of cEbf2 and cEbf3 expression. Because barrier insertion 
experiments indicate the necessity for lateral signal(s) in initiation of cEbf1 gene expression in somites, herein, 
we used the same experiment to evaluate whether endogenous Bmp2/4, which expressed abundantly in the 
lateral mesoderm and is crucial for mediolateral patterning of somites, can regulate expression of cEbf1 
gene. To check this possibility, pelets of chick DF-1 fibroblast cels transfected with a mammalian Noggin- 
RCASBP(A) virus or with empty vector (control) were implanted lateral or medial to crPSM or epithelial 
somites (arrowheads, Figure 5a,Bb1,Bb2,Ii,Jj1,Gj2). Injection of Noggin secreting cels lateral to the crPSM 
(arrowheads, Figure 5e,f) or epithelial somites (arrowheads, Figure 5g,h) resulted in complete loss of cEbf1 
expression in the sclerotome as compared to opposite somites and to control embryos (Figure 5c,d). These 

































Figure 5 Efect of BMPs gain and loss of function on cEbf1 gene expression. (a, b) Schematic diagrams 
showing the injection site of Noggin expressing cels lateral to crPSM (Bb1, magenta arrowhead) or to 
epithelial somite (Bb2, blue arrowhead). (c–h) Whole mount in situ hybridization and transverse sections 
of HH17-18 chick embryos folowing implantation of DF-1 control cels (c, d) and Noggin expressing cels 
(e–h) lateral to crPSM (e, f) and epithelial somites (g, h) show cEbf1 expression. (i, j) Schematic diagrams 
showing the injection site of Noggin expressing cels medial to crPSM (Jj1, magenta arrowhead) or to 
epithelial somite (Jj2, blue arrowhead). (k–p) Whole mount in situ hybridization and transverse sections 
 
of HH17-18 chick embryos folowing implantation of DF-1 control cels (k, l) and Noggin expressing 
cels (m–p) medial to crPSM (m, n) and epithelial somites (o, p) show cEbf1 expression. The blue 
arrowheads refer to the prospective site of the injected DF-1/Noggin cels and the green arrowheads 
indicate the prospective site of the injected cels. (q–v) Whole mount and transverse section of HH17-18 
chick embryos folowing implantation of BMP4 loaded beads at diferent concentrations; 50 (q, r), 100 
(s, t), and 150 μg/ml (u, v) show expression of cEbf1. In al photos, dashed lines indicate the site of 
transverse sections. Abbreviations: Ca, caudal; Cr, cranial; crPSM, cranial presomitic mesoderm; DM, 
dermomyotome; DSE, dorsal somitic epithelia; FP, floor plate; IM, intermediate mesoderm; LPM, lateral 
plate mesoderm; N, notochord; NT, neural tube; SI-SV, somites 1–5; Scl, sclerotome; Som, somitocoele; 
VSE, ventral somitic epithelia. Scale bars: c, e, g, k, m, o = 300 μm, q, s, u = 350 μm, d, f, h, l, n, p, r, t, 
v = 150 μm 
 
 
To check whether inhibition of Bmp signaling in the medial somitic domain can also down-regulate cEbf1 
expression, Noggin secreting cels were injected medial to the crPSM or epithelial somites (arrowheads) and 
unexpectedly caused a complete down-regulation of cEbf1 (Figure 5m,-Pp) as compared to control embryos 
(Figure 5k,l). On transverse sections, although Noggin implantation medial to the crPSM resulted in expansion 
of sclerotomal domain on the expense of the dermomyotomal domain, no cEbf1 expression was seen in the 
entire sclerotome (Figure 5n). 
 
In general, although inhibition of Bmps by Noggin injection induces sclerotomal cel formation, these cels 
failed to express cEbf1 gene. This suggests that Bmp signals are crucial for both induction of cEbf1 gene 
expression and maintenance of the identity of cels expressing cEbf1 gene. 
 
 
2.2.4 Efect of ectopic expression of Bmp4 on cEbf1 gene expression in somites 
 
Our previous study has shown that Afigel beads soaked in recombinant Bmp4 protein at concentrations 
below the apoptotic threshold, for example, 50–200 μg/ml, are functionaly active in the chick embryo (El- 
Magd et al., 2013). In this previous study, the accuracy and eficiency of the prepared Bmp4 beads as compared 
to control PBS beads were also confirmed. 
 
In the present study, we checked the efect of gain of Bmp4 function on cEbf1 expression by implanting 
beads soaked in Bmp4 protein into the crPSM. Implantation of Bmp4 beads (magenta arrowheads) at a lower 
concentration (50 μg/ml) resulted in not only up-regulation of cEbf1 but also its ectopic expression in regions 
that normaly did not express it (Figure 5q,r). For example, cEbf1 was ectopicaly expressed in the ventrolateral 
domain (yelow arrowhead), the dorsomedial region of the intersomitic boundary (green arrowhead), and 
the caudal somitic half (white arrowhead, Figure 5q). Transverse sections showed cEbf1 up-regulation in 
sclerotomal area adjacent to the NT (green arrowhead) and in the lateral sclerotomal domain which normaly 
does not express cEbf1 (yelow arrowhead, Figure 5r). In addition and as expected, the dermomyotome at the 
bead side was il-developed as compared to the contralateral side. 
 
To explore whether the concentration of Bmp4 is important for defining distinct domains of gene expression 
in the chick somitic mesoderm, and if cEbf1 responds to alterations in the level of signaling, beads soaked in 
100 and 150 μg/ml Bmp4 (stil below the apoptotic threshold) were placed in the crPSM. At moderate Bmp4 
concentration (100 μg/ml), cEbf1 expression was lost in the central sclerotomal domain (green arrowhead), 
but remained weakly in the medial domain (yelow arrowhead, Figure 5s,t). When the concentration of Bmp4 
protein increased to (150 μg/ml), cEbf1 was abolished in the somites (Figure 5u,v). 
 
In summary, these findings indicate that cEbf1 positively respond to the exogenous Bmp4 protein at a lower 
concentration. However, the gradual increase in Bmp4 concentration leads to gradual reduction of cEbf1. This 
means that cEbf1 expression is only increased by low dose of exogenous Bmp4 and is inhibited by higher doses. 
2.3 Role of cEbf1 in mediolateral patterning of somite 
 
 
2.3.1 Preparation of dominant negative Ebf1(ΔEbf1) construct 
 
To check the role of cEbf1 in the mediolateral patterning, we constructed a dominant-negative protein Ebf1 
(ΔEbf1), using an RCAS retroviral vectors, by deleting the 321 bp corresponding to the 107N-terminal amino 
acids (e.g., TSI and portion of DBD of the ful length mEbf1; Figure 6a). Similar construct derived from the 
Xenopus Ebf2 gene was shown to have a dominant-negative activity (Dubois et al., 1998). Although, such a 
deletion retains a portion of DNA binding domain (from amino acids [aa] 108–251), dimerization domain and 
TSII domain, it has been shown previously to obliterate Ebf1 DNA-binding activity (Hagman, Belanger, Travis, 
Turck, & Grosschedl, 1993). Thus, it is likely that over-expressing this truncated protein would titrate the 
native cEbf1 and prevent its normal function via the formation of cEbf1–ΔmEbf1 DBD heterodimers that are 
not able to bind DNA properly. In these mis-expression experiments, mouse ΔEbf1 was used as the complete 
coding sequence of mEbf1 is available and is highly homologous to chick cEbf1. Moreover, a similar mouse 
ΔEbf1 has been used successfuly to mis-express cEbf1 during NT development (Garcia-Dominguez, Poquet, 
Garel, & Charnay, 2003). Additionaly, the specificity of mouse ΔEbf1 to chick cels was further confirmed by 
the infection of chick DF-1 fibroblast cels with RCAS-ΔmEbf1 using anti-GAG staining. A high infection rate, 
revealed by intense brown coloration, was observed in RCAS-ΔmEbf1 infected DF-1 cels prior to viral harvest 

































Figure 6 Preparation and eficiency of RCAS-∆Ebf1. (a) Schematic diagram shows construction of a 
dominant negative Ebf1 (∆Ebf1, below) by deletion of the first 107 amino acids of mEbf1 (corresponding to 
TS) and portion of DBD). (b) Anti-GAG staining of the control DF-1 cels shows no positive reaction. (c) 
Anti-GAG staining of DF-1 cels infected with RCAS-∆Ebf1 reveals high infection rate as showed by 
intense brown coloration. (d, e) Transverse sections of HH18 chick embryos after injection of RCAS-∆Ebf1 
in both the lumen of the neural tube and the crPSM show N-Cad expression. (f, g) D5 chick embryo 
 
folowing injection of RCAS-∆mEbf1 in the crPSM shows mEbf1 expression. In al photos, dashed lines 
indicate the site of transverse sections. Abbreviations: Ca, Caudal; Cr, cranial; DBD, DNA binding 
domain; DM, dermomyotome; H1 and H2a, ancestral helices; H2d, duplicated helix; HLH, helix–
loop–helix; IPT/TIG, immunoglobulin-like plexins transcription factor; N, notochord; NT, neural tube; 
Scl, sclerotome; TSI, transactivation I; TSII, transactivation II; Zn, zinc finger motif. Scale bars: b, c = 
50 μm, d, e = 105 μm, f = 350 μm, g = 600 μm 
 
 
It has been reported that loss of cEbf1 function by over-expression of mouse ΔEbf1 can specificaly up- 
regulate N-Cad expression in the NT of chick embryos (Garcia-Martinez & Schoenwolf, 1992). To prove that 
∆Ebf1 used in this study can eficiently inhibit the endogenous activity of cEbf1, RCAS-∆Ebf1 was injected 
into both the crPSM and the lumen of the NT of HH9 chick embryos (n = 14). Folowing ~48 hr reincubation, 
alive embryos at stage HH17 (n = 12) were fixed and analyzed by in situ hybridization using an N-Cad mRNA 
probe. As expected, expression of RCAS-∆Ebf1 increased the expression domain of N-Cad both lateraly (blue 
arrowhead) and ventraly (magenta arrowhead) in the NT (Figure 6e, 10 out of 12 embryos showed this 
altered expression while the other two embryos showed a very slight up-regulation). Likewise, the control 
embryos (n = 14) which was injected with RCAS alone, showed normal expression of N-Cad in the ventricular 
layer of the dorsal portion of the NT (yelow arrowhead, Figure 6d, al harvested alive embryos (n = 12) 
showed this expression). This confirms that ΔEbf1 used in this study can eficiently inhibit the endogenous 
activity of cEbf1. It is also notable that injection of RCAS-ΔEbf1 in the crPSM resulted in up-regulation of N- 
Cad expression in the dermomyotome (red arrowhead, Figure 6e) compared to the control embryos (green 
arrowhead, Figure 6d). This injection also led to formation of dermomyotome bigger than the control one. 
 
To confirm the infection with RCAS-∆Ebf1 and to ascertain that the RCAS-ΔEbf1 can consistently achieve 
high-level infection in the somites, the PSM of 5 HH9-10 embryos were injected with RCAS-∆Ebf1, in order 
to infect the majority of somitic tissue in ovo, and embryos were harvested at Day 5 for whole mount in situ 
hybridization with an antisense riboprobe for mEbf1. The mEbf1 was extensively expressed in the somites of 
al injected embryos (Figure 6f). Transverse section showed a robust expression of mEbf1 in the sclerotome 
and the dermomyotome as wel as weak expression ventral to aorta (Figure 6g). No expression was detected in 
the somite of the contralateral side. This extensive viral distribution along with up-regulation of N-Cad in the 
NT confirmed that RCAS-ΔEbf1 produces high-level infection in the somites and any subsequent molecular 
changes should be due to ∆Ebf1 misexpression, which was assumed to be loss of function as previously stated 
(Dubois et al., 1998; Garcia-Dominguez et al., 2003; Hagman et al., 1993). 
 
To investigate the efect of ΔEbf1 misexpression/Ebf1 loss of function on the mediolateral patterning of 
somites, RCAS-∆Ebf1 was injected into the PSM at stage HH9-10 and the medial sclerotomal marker, cPax1, 
the dermomyotomal marker with highest expression in the lateral dermomyotomal lips, cPax3, and the lateral 




























Figure 7 Molecular analysis of ∆Ebf1 injected embryos. (a–e) Whole mount in situ hybridization and 
transverse sections (c, e) of HH15-16 chick embryos folowing injection of either RCAS (a), RCAS-∆Ebf1 
(b), or RCAS-∆Ebf1+ Ebf1 (d) in the crPSM show cPax1 expression. (f) Whole mount acridine orange 
staining of HH16 chick embryo folowing injection of RCAS (left side) and RCAS-∆Ebf1 (right side) in the 
crPSM shows a similar level of apoptotic cels in both sides (arrowheads). (g–l) Whole mount and 
transverse sections of HH15-16 chick embryos folowing injection of either RCAS (g, j) or RCAS-∆Ebf1 (h, 
k) in the crPSM show cEbf3 (g–i) and cPax3 (j–l). Regions between each two blue arrowheads refer to 
injection site. Abbreviations: DM, dermomyotome; N, notochord; NT, neural tube; Scl, sclerotome. Scale 




2.3.2 Inhibition of cEbf1 completely down-regulates the medial sclerotomal marker, 
cPax1 
 
We previously proved that cEbf1 expression precedes cPax1 in the somites (El-Magd et al., 2015) and both 
genes are downstream targets of the Shh signaling pathway (Christ, Huang, & Wilting, 2000; El-Magd et 
al., 2015). To determine whether cEbf1 regulates cPax1 expression, RCAS-ΔEbf1 was injected into the crPSM 
of HH9-10 chick embryos (n = 14) which were then reincubated for 24 hr until stage HH15-16 (number of 
alive harvested embryos = 12). Analysis of cPax1 expression in ∆Ebf1 injected embryos showed complete 
down-regulation of this expression in somites (red arrowhead, Figure 7b, in 10 embryos, while the other two 
embryos showed a slight reduction of cPax1 expression) compared to control embryos injected with empty 
RCAS (Figure 7a, in al four alive harvested embryos). Transverse sections not only showed the complete loss 
of cPax1 expression (red arrowhead) but also revealed normal epithelial mesenchymal transition, but with 
hypertrophied dermomyotome on the injected side compared to the contralateral noninjected side (Figure 7c). 
The lost cPax1 expression was rescued when embryos were injected with RCAS-∆Ebf1 co-transfected with wild 
type Ebf1 (Figure 7d,e). These findings indicate that cPax1 expression in the sclerotome lies downstream to, 
and is dependent on, the cEbf1 activity. 
 
The mechanism for down-regulation of cPax1 was investigated by analyzing ∆Ebf1 embryos for changes 
in levels of celular apoptosis. To identify whether down-regulation of cPax1 is due to changes in cels fate 
or cels loss due to increased cel death, whole mount acridine orange staining was used to show apoptotic 
cels. HH9 embryos (n = 15) were injected with RCAS-∆Ebf1 and empty RCAS (control) in the right and left 
crPSM, respectively. Folowing incubation for 36 hr, the profile of apoptotic cels in ΔEbf1 injected side (red 
arrowhead, Figure 7f, in al 12 alive harvested HH17 embryos) was similar to that seen in the control side (blue 
arrowhead, Figure 7f). This indicates that the loss of cPax1 expression is not a secondary consequence of loss of 
a subset of sclerotomal cels, but it is rather a very early molecular defect caused by ∆Ebf1 misexpression/Ebf1 
loss function in the sclerotome. 
 
 
2.3.3 Inhibition of cEbf1 up-regulates the lateral sclerotomal marker, cEbf3 
 
Since ∆Ebf1 misexpression/Ebf1 loss function down-regulates the medial sclerotomal marker cPax1, it is 
also possible that ∆Ebf1 can change the cel fate of somitic tissues. To explore this, the efect of the RCAS-∆Ebf1 
on the expression of a lateral sclerotomal marker, cEbf3, was checked. RCAS-∆Ebf1 was injected in the crPSM 
of HH9 embryos (n = 15) and these were then fixed at stage HH16 (number of alive harvested embryos = 12). 
As expected, cEbf3 expression was up-regulated in somites of the ∆Ebf1 embryos (red arrowheads, Figure 7h,i, 
in 10 embryos, while the other two embryos showed slight cEbf3 up-regulation) as compared to the control 
embryos (Figure 7g, in al 12 harvested alive embryos). This medial expression of the lateral marker cEbf3 
indicates that the sclerotome becomes lateralized in absence of Ebf1. 
 
 
2.3.4 cEbf1 inhibition up-regulates the dermomyotomal Pax3 
 
Complete loss of the medial sclerotomal marker cPax1 and up-regulation of the lateral sclerotomal marker 
cEbf3 folowing ∆Ebf1 misexpression/Ebf1 loss function suggest that the medial cels may have adopted 
a lateral identity. Therefore, it is possible that mis-expression of ∆Ebf1 could also up-regulate cPax3 (a 
dermomyotomal marker with highest expression in the lateral dermomyotomal lips). RCAS-∆Ebf1 or empty 
RCAS was injected into the crPSM of HH9 chick embryos and these were reincubated until reaching stage 
HH15. In control embryos (n = 5), cPax3 was localized mainly in the lateral dermomyotomal lips with only a 
very weak expression in the medial dermomyotomal lips (Figure 7j, in al four alive harvested embryos). In 
contrast, ∆Ebf1 injected embryos (n = 15) showed up-regulation of cPax3 in the medial and lateral domains 
of the dermomyotome (red arrowhead, Figure 7k,l, in 11 embryos, while the other one alive harvested embryo 
showed unremarkable up-regulation). This medial expansion of cPax3 means that the somitic cels adopt a 





Our prior two studies revealed that cEbf1 expression in the medial sclerotome is regulated by Shh signals 
from the notochord, while cEbf2,3 expression in the lateral sclerotome is regulated by the lateral mesoderm- 
derived Bmp4 signals (El-Magd et al., 2013, 2015). However, these two studies lacked some important 
information regarding: (a) the regulation of cEbf1 early expression in the crPSM; (b) the efect of the lateral 
signals (mainly Bmp4) on the medial sclerotomal marker, cEbf1; (c) the efect of axial signals (mainly Shh) on 
the lateral sclerotomal markers, cEbf2/3; and (d) the role of cEbf genes in somites patterning (due to lack of 
loss and/or gain of function experiment on cEbf genes). Therefore, we conducted the present study to complete 
the previous work and to check whether cEbf1 could be downstream targets in Shh and Bmp4 signaling cascade 
regulating the mediolateral patterning of the somites. 
 
The first gap addressed in the present study was the regulation of cEbf1 early expression in the crPSM. 
Our previous study showed that cEbf1 is expressed in the crPSM, but the tissues and signals regulating (by 
induction and/or maintenance) this expression have not been determined (El-Magd et al., 2015). Herein, we 
reported for the first time that the lateral mesodermal signals, but not the notochord signals, are the initial 
inducer of cEbf1 expression in the crPSM and the notochord signals are mainly required for sclerotomal 
formation and hence maintenance of this expression (Figure 8). This overal conclusion was based on the 
finding that cEbf1 expression can be induced in the crPSM in isolation from the notochord as insertion of a 
medial barrier at the level of caudal PSM folowed by short incubation time resulted in only a slight reduction 
of cEbf1 expression in the crPSM. In contrast, isolation of the crPSM from the lateral mesoderm completely 
down-regulates cEbf1 expression, suggesting induction of cEbf1 expression by lateral signals. Folowing this 
type of operation, the sclerotomal cels are formed normaly, and characterized by high rate of proliferation 
(Cheng, Alvares, Ahmed, El-Hanfy, & Dietrich, 2004; Dietrich et al., 1997), however cEbf1 was not initiated 
in these cels. Unlike cEbf1, the domain of the medial sclerotomal marker Pax1 was expanded folowing 
separation of the somitic mesoderm from the lateral mesoderm (Cheng et al., 2004; Dietrich et al., 1997). 
This suggests that cEbf1 is a novel medial sclerotomal marker whose expression is induced by lateral signals. 
However, these lateral signals are not required for maintenance of cEbf1 expression since this expression was 

































Figure 8 Schematic diagram showing the molecular regulation of cEbf expression at level of the crPSM, 
epithelial (immature) somites, and mature (diferentiated) somites of by Bmp4 and Shh. cEbf1 expression 
in the crPSM is induced by low level Bmp4 from the lateral mesoderm. Once the somites formed, cEbf1 
expression is maintained in the ventromedial epithelial somites and the medial sclerotome by the 
notochord-derived Shh signal and Bmp signals (probably Bmp4 from the dorsomedial dermomyotomal 
lip?). cEbf2 and cEbf3 expression in the lateral somitic domains of immature somites and later in the 
lateral sclerotome is induced and maintained by Bmp4 from the lateral mesoderm. High level Shh 
antagonize Bmp4 efect on cEbf2 and cEbf3 genes and hence prevent their expression domain to expand 
medialy. Abbreviations: DM, dermomyotome; LPM, lateral plate mesoderm; LS, lateral somatic domain; 
MS, medial somatic domain; N, notochord; NT, neural tube; Scl, sclerotome 
 
 
Tissue manipulations supported by Shh gain and loss of experiments in the present study and our previous 
study (El-Magd et al., 2015) indicate that notochord-derived Shh signals are necessary for maintenance of 
cEbf1 expression in the ventromedial part of the immature (epithelial) somites and further in the medial 
sclerotomal domain (Figure 8). In paralel, Shh knock-out mice display close to normal, but transient, Pax1 
expression in the medial sclerotome, suggesting that Shh may act to maintain and/or expand the population 
of Pax1-positive cels, rather than induce these cels (Chiang et al., 1996). Furthermore, Shh as a mitogen, has 
the ability to completely rescue normal somite proliferation after separation of somites from axial structures 
or after removal of notochord (Marcele et al., 1999; Teilet et al., 1998). Therefore, Shh might serve to expand 
a population of cEbf1-positive cels induced by factor(s) emanating from the lateral plate, most likely Bmp2/4. 
 
Therefore, the second issue addressed in the present study was whether Bmp4 is the lateral signal that 
induces cEbf1 expression in the somites. In support of this idea, inhibition of Bmps by implantation of 
Noggin-expressing cels between crPSM and either axial or lateral structures downregulated cEbf1 and ectopic 
overexpression of low dose of Bmp4 in the crPSM upregulated cEbf1. Thus, Bmp4 is the lateral mesoderm- 
derived signal that induces cEbf1 expression in crPSM and epithelial somites (Figure 8). Unlike the results 
obtained from the lateral barrier insertion which revealed no efect for the lateral signals on maintenance of 
cEbf1 expression in the medial sclerotome, results from loss of Bmp function showed that ectopic noggin (Bmp 
antagonist) between the epithelial somites and the NT completely reduces cEbf1 expression. This indicates that 
Bmp required for maintenance of medial cEbf1 expression is not derived from lateral tissues. The roof plate of 
the NT and the overlying ectoderm are further two sources of Bmp4 signals (Monsoro-Burq, 2005; Monsoro- 
Burq & Le Douarin, 2000). This dorsal Bmp4 is unlikely to have a regulatory efect on cEbf1 expression as 
ablation of ectoderm (data not shown) or NT does not change cEbf1 expression, and dorsal Bmp4 signals 
mainly target the dorsal somitic cels to negatively regulate epaxial myogenesis (Sela-Donenfeld & Kalcheim, 
2002). Therefore, it is possible that the Bmp source for maintaining medial cEbf1 expression may be intrinsic 
(from the somites). In agreement with this notion, Bmp2/4 and smad1 (Bmp activator) are expressed in the 
dorsomedial dermomyotomal lip at HH11-13 stage (Danesh et al., 2009; Faure, de Santa Barbara, Roberts, & 
Whitman, 2002), the same stage as microsurgical manipulations and Noggin injections were performed in this 
study. Thus, it is possible that these medial intrinsic Bmps may maintain cEbf1 expression in medial somitic 
domain (Figure 8). To check this possibility, tissue ablation experiments by removing the dermomyotome 
domain alone is required to check whether cEbf1 expression wil be maintained or not. Overal, it is conceivable 
that an initial lateralizing signal conveyed by Bmp4 produces a plastic polarity in the somite, and that axial 
signals (Shh), coming later, fix and elaborate the polarity. 
 
Regarding regulation of cEbf2 and cEbf3 expression in the somites, our previous study revealed that lateral 
mesoderm derived-Bmp4 signal induces and maintains this expression (El-Magd et al., 2013). However, in 
this previous work, the efect of notochord signals (Shh and Noggin) on cEbf2 and cEbf3 expression was 
not investigated. Again, this third gap was addressed in the present study. Previous studies have indicated 
that notochord removal results in up-regulation of the lateral somitic marker, Sim1, which is expressed first 
in the entire lateral half of the epithelial somite, and further localized in the lateral dermomyotome and 
sclerotome) (Christ et al., 2000; Dockter, 2000). Consistent with this, ectopic cEbf3 expression is induced in 
the medial sclerotomal domain folowing isolation of somitic mesoderm from axial structures by notochord 
removal or medial barrier implantation. This suggests that the notochord produces signal to antagonize cEbf3 
expression and thus blocks cEbf3 in medial somite. This signal is unlikely to be Shh because inhibition of Shh 
by cyclopamine does not afect cEbf2 and cEbf3 expression. On the other hand, although ectopic application of 
Shh inhibits this expression in a dose-dependent manner (with a low dose [0.5 μg/μl], the expression remained 
normal, with a moderate dose [1 μg/μl], the expression became slightly reduced, with a high dose [2 μg/μl], the 
expression was completely extinguished), this change may be secondary to change in identity of the cels after 
over-expression of Shh, that is, the lateral sclerotomal cels were respecified to be medial cels and hence cEbf2 
and cEbf3 expression was lost. Similarly, previous studies have indicated that relatively high concentrations 
of Shh maintain the expression of the sclerotomal markers (Pax1, Nkx3.2, and Sox9; Cairns et al., 2008; 
Chiang et al., 1996) and repress the dermomyotomal markers (Pax3 and Pax7; Hammond et al., 2007) through 
medialization of somitic cels. Taken together, Shh is not the notochordal signal that directly inhibits cEbf3 
expression. It is likely that another molecule from the notochord is required to antagonize Bmp4 and so 
inhibits expression of cEbf3 medialy. A good candidate gene with these criteria is Noggin, since it is a medial 
signal secreted from the notochord (McMahon et al., 1998) and acts either synergisticaly with Shh to activate 
medial sclerotomic markers, such as Pax1 (Dockter & Ordahl, 2000) or alone to inhibit the lateralization efect 
of lateral mesoderm signals, especialy Bmp4 (Tonegawa & Takahashi, 1998). In agreement, Noggin over- 
expression in the lateral PSM results in complete loss of cEbf2 and cEbf3 (El-Magd et al., 2013). 
 
Before this study, there is no definitive work studying the ML molecular identity of the sclerotome. Although, 
we have previously found that the expression domains of cEbf1 and cEbf2, 3 molecularly define the medial 
and the lateral portion of the sclerotome, respectively (El-Magd et al., 2013, 2015), the actual function 
of cEbf genes during mediolateral patterning of somites was not determined due to lack of Ebf gain and 
loss of function experiment. Again, this fourth gap was addressed in the present study. Mis-expression of 
∆Ebf1, which probably causes cEbf1 loss of function (Dubois et al., 1998; Garcia-Dominguez et al., 2003; 
Hagman et al., 1993), revealed a possible significant role for cEbf1 in maintenance of medial somite identity 
(Figure 8). When ∆Ebf1 mis-expressed, the medial sclerotome marker cPax1 was completely down-regulated 
and the somite assumed a lateral identity as revealed by up-regulation of the lateral dermomyotome marker 
cPax3 and the lateral sclerotome marker cEbf3. This suggests that cEbf1 may be a potential determinant 
of medial somite identity. Therefore, cEbf1 may be necessary for commitment (specification) of somitic 
precursor to a sclerotomal fate because its inhibition results in complete loss of Pax1 which is the key regulator 
for sclerotomal induction and specification (Borycki et al., 1998; Christ, Huang, & Scaal, 2004; Dockter & 
Ordahl, 2000; Peters et al., 1999; Rodrigo, Hil, Baling, Munsterberg, & Imai, 2003). This means that the 
developmental function of cEbf1 may be required for directing the medial somite to form sclerotome. Further 
investigations are required to identify whether cEbf1 can directly induce Pax1 by binding to its promoter or 
indirectly by maintaining the identity of its expressing cels. 
 
The classical model depicting the ML patterning of the somite indicates that Bmp4 is only needed for 
lateralization of somites and should be completely inhibited, by Noggin, in the medial domain to keep the 
ML identity (Danesh et al., 2009; Hirsinger et al., 1997; Nowicki, Takimoto, & Burke, 2003; Pourquie et al., 
1995, 1996; Staford et al., 2011, 2014; Stern & Piatkowska, 2015; Tonegawa et al., 1997). In these studies, Bmp 
signaling was not manipulated at a very low concentration. This prompts us to check the efect of diferent 
Bmp concentration. Indeed, we have found that a diferential concentration of Bmp4 is required along the 
ML axis of somitic mesoderm to keep the medial and lateral identity of cEbf expressing sclerotomal cels. 
Moderate and high Bmp4 levels favor for the formation of lateral sclerotome may be through activation of 
the lateral markers cEbf2, 3 and inhibition of the medial sclerotomal marker cEbf1. However, a lower level is 
required for establishment of the medial somitic domain via activation of cEbf1. Loss of the medial sclerotomal 
markers caused by moderate and high level of the Bmp4 raised two possibilities: (a) the cels that would 
normaly contribute to the medial sclerotome died in response to Bmp4, or (b) these cels survived but were 
transformed to another cel type. The first possibility is unlikely because Bmp4 was used at concentrations 
below levels that normaly induce apoptosis. In agreement with the second possibility, moderate and high 
doses of Bmp4 lateralized the somites, that is, the medial sclerotomal cels expressing cEbf1 transformed into 
lateral sclerotomal cels expressing cEbf2 and cEbf3. This also indicates that only low levels of Bmp4 are able 
to keep the identity of medial sclerotomal cels. The pattern and timing of Bmp signaling along the ML axis of 
the embryo, as revealed by phosphorylated Smad1 activity (Faure et al., 2002), are consistent with the current 
finding that low doses of Bmp signaling pattern the medial somites. At stages HH11-13, phosphorylated Smad1 
is detectable strongly within the lateral plate mesoderm, moderate in the lateral somites, and weakly in the 
medial somites. These findings are novel and disagree with the old model for ML patterning. Therefore, the 
old theory for influence of Noggin and Bmp on the ML identity within somites should be revised. We propose 
a model for regulation of cEbf genes in the somitic mesoderm along the ML axis during normal embryogenesis 
(Figure 8). Bmp4 induces cEbf genes expression in the crPSM and immature somites. Subsequently, the 
mature somite acquires ML polarity: the lateral portion expressing cEbf2 and cEbf3 is established by high 
Bmp4 and the medial one expressing cEbf1 is formed by high Shh and low Bmp4. This means that both Shh and 
Bmp4 regulate cEbf expression in somites in a morphogen-like fashion but in opposite directions. However, 
in the absence of any information on the concentration of Bmp4 and Shh proteins that difuse out of the 
beads, estimation of the efective dose of these two proteins remains speculative. Another problem of using 
bead experiments is that the obtained efect may be attributed to the duration of exposure rather than the 
concentration (dose–response). For example, at lower concentrations the protein may run out of the bead 
quicker. Therefore, further in vitro studies (somite explant culture) are recommended to accurately estimate 
the efect of diferent concentrations and duration of Bmp4 and Shh on Ebf genes expression. 
 
Striking similarities exist between mammalian and avian EBF expression in the somites, where both chick 
(El-Magd et al., 2013, 2015) and mouse Ebf genes (Garel et al., 1997; Kieslinger et al., 2005) are expressed 
in medial (Ebf1) and lateral (Ebf2 and Ebf3) sclerotomal domains. This therefore suggests a common 
evolutionary conserved role for these genes in patterning of the somite along the ML axis. In anamniotes, 
Xenopus xEbf2, 3 and zebrafish zEbf2, 3 have similar lateral somitic expression as their amniote counterparts 
(Dubois et al., 1998). Moreover, the cephalochordate EBF in Amphioxus, AmphiCoe, is notably expressed in 
the mesoderm at the extremely lateral portion of the mature somites and in the adjacent lateral mesoderm 
(Mazet, Masood, Luke, Holand, & Shimeld, 2004). This suggests that the vertebrate ancestors of EBF 
expressing cels originaly resided in the lateral somitic/lateral mesoderm interface. This could also explain 





To the best of our knowledge, this may be the first study to demonstrate that cEbf1 plays a critical role 
in mediolateral patterning of somites. As a specific medial sclerotomal marker, cEbf1 induces the medial 
sclerotomal marker, Pax1, and antagonizes the lateral sclerotomal marker cEbf3 and the dermomyotomal 
marker (with abundant lateral expression) cPax3. Its expression is maintained by Shh from the notochord. 
However, unlike al other known medial markers, cEbf1 expression in the medial somitic domain is induced 
by low levels of the lateral plate derived Bmp4. The other two chick Ebf genes, which act as lateral sclerotomal 
markers (especialy cEbf3) are induced and maintained by Bmp4 and inhibited by high dose of Shh. This 
indicates that Bmp4 activity is required along the ML axis of the somites. These striking findings are novel and 
give a new insight on the role of Bmp on ML patterning of somites through regulation of Ebf genes expression. 
 
 
5 MATERIALS AND METHODS 
 
 
5.1 Embryo preparation 
 
Fertile hens' eggs were incubated at 38°C, 80% relative humidity to give embryos at stages HH9-D5 
(Hamburger & Hamilton, 1951). 
 
 
5.2 Embryo manipulations 
 
Al microsurgeries were performed on chick embryos at HH11-13 when the PSM is at its maximum length, 
ensuring the largest target area possible. Therefore, al induction experiments for cEbf1 were carried out on a 
large area of crPSM about 5–9 somites length. Manipulations were performed at both crPSM (either during or 
prior to initiation of cEbf1 or cEbf2, 3 expression, respectively) and epithelial somite level (after induction of 
cEbf expression) to isolate the tissues both inducing and maintaining expression of cEbf genes, respectively. 
This was achieved by either insertion of impermeable barriers or ablation of candidate tissues. 
 
 
5.2.1 Barrier insertion 
 
A thin Nile blue stained tungsten needle (STN) was used to make a slit of 5–8 somites length either medialy 
between the paraxial mesoderm (epithelial somites or crPSM) and the NT or lateraly between the paraxial 
mesoderm and lateral mesoderm. This slit was then deepened inwardly to the notochord and a piece of thin, 
sterilized aluminum foil was rapidly inserted. Folowing barrier insertion, excess PBS was removed from the 
embryo using tissue paper thus sealing the slit. 
 
 
5.2.2 Axial structure removal 
 
The NT and notochord were separated from the paraxial mesoderm using a STN then two transverse 
incisions were made at the anterior and posterior ends of the NT/notochord segment and the ablated segment 
rapidly removed from the egg. 
 
 
5.2.3 Neural tube removal 
A gap between the NT and crPSM on both the left and right sides of the NT were made using STN. A caudal 
transverse incision was made in the NT, and the NT was raised with STN in a caudal to cranial direction. The 
floor of the NT was carefuly separated from the underlying notochord then a transverse incision was made 
through the NT at the cranial end of the operation region releasing the NT from the embryo. 
 
 
5.2.4 Application of cyclopamine and beads 
 
Application of cyclopamine and beads were performed as previously described (El-Magd et al., 2013, 2015; 
El-Magd, Saleh, El-Aziz, & Salama, 2014). 
 
 
5.3 Preparation and injection of RCAS-dominant negative Ebf1 (ΔEbf1) 
 
The retrovirus RCASBP(A) was used to express dominant negative Ebf1 (∆Ebf1) protein in the chick embryo 
somites using the same strategy as described by (Morgan & Fekete, 1996) and as summarized in the Figure S1. 
Briefly, an expression plasmid containing ful length mouse mEbf1 was obtained as a gift from Prof. Roessler et 
al. (2007). The ΔEbf1 coding sequence used in this study was constructed by deletion of the 5′ 321 bp of coding 
sequence corresponding to the N-terminal 107 aa using polymerase chain reaction (PCR) with the folowing 
two primers: a 5′primer CATGCCATGGTCCACTACCGGCTCCAGCTC with a Nco1 restriction site (CCATGG) 
preceding codon 108 (TCC) and a 3′primer GATCGAATTCTCACATGGGAGGGACAATCATATGC that spanned 
the stop codon (TCA) folowed by an EcoR1 restriction site (GAATTC). This truncation is corresponding to 
both N-terminal transactivation domain (from aa 1 to 34) and portion of DNA binding domain (from aa 35 to 
107). A proofreading DNA polymerase, Pfu (Promega) was used to minimize errors during the PCR. The PCR 
product of the truncated mEbf1 (1.455 kb) was cut by Nco1 and EcoRI into large Nco1-NcoI fragment (1.248 kb) 
and smal NcoI-EcoRI fragment (0.207 kb). The two fragments were separately cloned into Slax12Nco adaptor 
plasmid, where the smaler fragment was ligated first then the larger one, folowing the standard cloning 
procedures. Because it is two piece cloning, orientation of the insert was verified by KpnI, which cuts at two 
unique sites; one 3′ to the insert in Slax12 Nco and the other 0.890 Kb into the insert sequence to give either 
a 0.980Kb fragment for correct direction or a 0.893Kb fragment for incorrect orientation. These clones were 
sequenced (Geneservice, Cambridge, UK) to ensure that no mutations occurred during PCR as wel as to 
confirm correct orientation. The entire ∆Ebf1 fragment was then excised by digestion with ClaI. The ClaI-Cla1 
fragment of Slax12Nco-ΔEbf1 was cloned into RCASBP(A) (Cla1 digested and dephosphorylated by alkaline 
phosphatase) and digested with EcoRV to confirm the orientation of the insert. Characteristic bands of 5.121 
and 0.823 kb are produced from the correct orientation and 3.041 and 2.543 kb fragments from the incorrect 
orientation. 
 
Virus was generated according to protocols described by (Morgan & Fekete, 1996). In brief, once the RCAS 
vector has been built and a clone with the correct insert orientation has been selected, the proviral vector is 
amplified as bacterial plasmid to generate large quantities of proviral DNA. This DNA is then transfected into 
chicken embryo fibroblast cel line, DF1 (CRL-12203), using standard in vitro techniques to generate producer 
cels, in which active virus forms (virions) are shed into the culture medium. The supernatant containing 
infectious virions was colected and the virus harvested and then concentrated to yield high-titre viral stocks. 
The majority of embryos were injected at stage HH9-10. A smal window in the egg shel was opened and the 
axis of the embryo was oriented to be paralel to the micropipette with the tail closest to the needle. The needle 
was inserted in the crPSM, under the ectodermal layer labeled by Nile blue stain, and about 0.1 μl viral stock 
(1 x 108) was slowly injected as previously described (Morgan & Fekete, 1996). 
 
 
5.4 Anti-GAG immunostaining of viraly infected DF-1 cels 
 
The infection of chick DF-1 cels with RCASBP-ΔEbf1 was monitored using 3C2 hybridoma supernatant 
mouse-anti-GAG staining. Briefly, cels were rinsed with PBS, fixed with 4% PFA (15–30 min, at room 
temperature) washed with PBS (15 min) and pre-blocked in the blocking solution (DMEM media containing 
10% fetal bovine serum [FBS], 0.05% Triton X-100) for 1 hr. The cels were incubated in 3C2 antibody (diluted 
1:4 in DMEM containing 10% FBS plus 0.05% Triton X-100, 30 min before using) for 1 hr at room temperature 
(RT). After rinsing twice in PBS, the cels were incubated in Biotin conjugated Rabbit anti-mouse IgG, IgM, 
secondary antibody (diluted 1:200 in blocking solution at least 30 min prior to use) for at least 30 min at RT. 
Folowing rinsing with PBS, avidin and biotinylated horseradish peroxidase macromolecular complex reagent 
(made 30 min before use, using 20 μl of A and B in 2 ml PBS) was added and samples incubated for 30 min at 
RT. After rinsing twice in PBS, the cels were washed 15 min in distiled water. Color was developed for 2–5 min 
in dark at RT using Diamino Benzidine as a substrate. The reaction was stopped by rinsing several times with 
water. When infection was 50% or higher cels were transferred into bigger flask (T75) for further processing. 
 
 
5.5 Whole mount in situ hybridization 
 
Harvested embryos were washed in PBS and fixed in 4% paraformaldehyde, overnight at 4°C. Whole-mount 
in situ hybridization using DIG-labeled RNA probes was performed as described previously (Nieto, Patel, 
& Wilkinson, 1996). Chick probes used were: cEbf1, 696 bp; cEbf2, 405 bp; cEbf3, 504 bp (El-Magd et al., 
2014); mEbf1 696 bp (kind gift of Prof. Grosschedl); cN-Cad (kind gift of Prof. Anthony Graham); cPax3 (Otto, 
Schmidt, & Patel, 2006); and cPax1 (kind gift of Prof. Bodo Christ). Whole mount embryos and sections were 





Fresh embryos were stained with acridine orange (AO) by diluting a stock solution of 1 mg/ml AO with 
PBS to give a working concentration of 0.1 μg/ml. Embryos were stained for approximately 5 min then briefly 
washed twice in PBS to remove the excess dye. After staining, embryos were covered with a cover slip and 
observed with a Leica confocal microscope (TCS SP5). AO shows selective afinity for chromatin of apoptotic 
cels, resulting in bright fluorescence. 
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